A group of researchers from the Faculty of Medicine of the University of São Paulo, Brazil studied the efficacy of the use of cannabidiol (CBD), for the reduction of emotional exhaustion and exhaustion of health professionals who care for patients with the COVID-19 disease.
The open-label study included 120 healthcare professionals with extreme exhaustion. The dosing experiment was divided into two: 61 participants were given 150 mg twice daily versus 59 participants with standard care. Each was given 300 mg of CBD in addition to the standard medication.
According to the emotional exhaustion subscale of Maslach’s Burnout Inventory, CBD treatment helped decrease significantly on day 14 and day 28. However, 5 patients experienced serious effects such as 4 of elevated liver enzymes and 1 case of severe pharmacotherapy.
The researchers concluded that CBD in general could benefit the symptoms of extreme tiredness in these types of health professionals.
“In this study, CBD therapy reduced symptoms of burnout and emotional exhaustion among healthcare professionals working with patients during the COVID-19 pandemic. However, it is necessary to balance the benefits of CBD therapy with possible unwanted or adverse effects. Future double-blind, placebo-controlled clinical trials are needed to confirm the current findings.”
Read the study: https://bit.ly/34plWj6
in Costa Rica. 
